Journal article · 2026 · Open access

Low-risk breast cancer survivors' expectations for symptom discussions during oncology follow-up.

Jessica R. Schumacher, Bret M. Hanlon, Catherine Rae Breuer, Lily N. Stalter, Grace McKinney, Winifred L. S. Commers, Kristine L. Kwekkeboom, Kathryn E. Flynn, James Edward Haine, Heather B Neuman

JCO Oncology Practice, 22(10_suppl), 470 · Published 1 October 2026 · DOI 10.1200/op.2026.22.10_suppl.470

Open PDFView at the publisherCite this paper

In brief

“Low-risk breast cancer survivors' expectations for symptom discussions during oncology follow-up.” is a 2026 journal article by Jessica R. Schumacher and 9 co-authors, published in JCO Oncology Practice. OpenAlex counts 0 citations as of 22 November 2026. It is open access: the full text is free to read at JCO Oncology Practice.

Citations
0
Authors
10

Abstract

470 Background: Over 2 million low-risk breast cancer survivors need follow-up, addressing multiple symptom and well-being domains within time-limited oncology/survivorship visits. Although integrating PRO assessments into routine care facilitates symptom reporting, failure to discuss them in follow-up contributes to undermanaged patient-driven concerns. We assessed survivors' expectations for discussing symptoms with their oncology/survivorship team. Methods: We analyzed randomized controlled trial data from survivors of stage I, ER/PR-positive/HER2-negative breast cancer, 6–36 months post-diagnosis with no chemotherapy. Two weeks before oncology visits, survivors completed a PRO symptom survey, co-developed with stakeholders and based on ASCO survivorship guidelines, assessing symptoms related to distant/local recurrence, endocrine therapy, breast/chest wall discomfort, lymphedema, body image, sexual health, and mental health. Post-visit, survivors reported whether they expected to discuss symptoms with their team. Expectations did not differ by arm; arms were combined and summarized descriptively. Results: 99 survivors completed 216 pre-visit PRO surveys. Participants were a median 63 years (range 36–86), 12.5 months post-diagnosis, and 51.9% of assessments had 1+ threshold-level symptoms. The most reported symptoms were endocrine therapy and breast/chest wall discomfort (Table). Expectations to discuss symptoms were highest for breast concerns (100%), breast/chest wall discomfort (78.9%), endocrine therapy (70.9%), sexual health (70%), and distant recurrence (57.9%), and lower for lymphedema (50%), mental health (31.3%; 20% anxiety, 50% depression), and body image (22.2%). Conclusions: In this low-risk cohort, a meaningful proportion reported threshold-level symptoms. Although assessed symptoms represent ASCO survivorship domains, more survivors expected to discuss physical/medical than psychosocial symptoms, suggesting patients may not expect psychosocial concerns addressed in time-limited oncology visits. Future work should help oncology providers address patients' priority symptoms across all domains. Clinical trial information: NCT05047575 . Domain Patients with Symptoms (N=99) n (%) Assessments with Symptoms (N=216) n (%) Symptoms Patients Expected to Discuss n/N* (%) Distant Recurrence 20 (20.2) 27 (12.5) 22/38 (57.9) Endocrine Therapy Symptoms 36 (36.4) 50 (23.1) 32/48 (66.7) Endocrine Therapy-Missed Dose 7 (7.1) 7 (3.2) 7/7 (100) Breast Concerns 6 (6.1) 8 (3.7) 8/8 (100) Body Image Concerns 9 (9.1) 11 (5.1) 2/9 (22.2) Breast/Chest Wall Discomfort 30 (30.3) 42 (19.4) 30/38 (78.9) Lymphedema Symptoms 15 (15.2) 24 (11.1) 10/20 (50) Sexual Health 19 (19.2) 22 (10.2) 14/20 (70) Mental Health 13 (13.1) 19 (8.8) 5/16 (31.3) *Threshold-level symptoms with matching post-visit survey. Total N can exceed (multiple symptoms per domain) or fall below (post-visit non-response) column 3.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Schumacher, J. R., Hanlon, B. M., Breuer, C. R., Stalter, L. N., McKinney, G., Commers, W. L. S., Kwekkeboom, K. L., Flynn, K. E., Haine, J. E., & Neuman, H. B. (2026). Low-risk breast cancer survivors' expectations for symptom discussions during oncology follow-up. JCO Oncology Practice, 22(10_suppl), 470. https://doi.org/10.1200/op.2026.22.10_suppl.470

MLA 9

Schumacher, Jessica R., et al. “Low-risk breast cancer survivors' expectations for symptom discussions during oncology follow-up.” JCO Oncology Practice, vol. 22, no. 10_suppl, 2026, p. 470. https://doi.org/10.1200/op.2026.22.10_suppl.470.

Chicago

Schumacher, Jessica R., Bret M. Hanlon, Catherine Rae Breuer, Lily N. Stalter, Grace McKinney, Winifred L. S. Commers, Kristine L. Kwekkeboom, Kathryn E. Flynn, James Edward Haine, and Heather B Neuman. 2026. “Low-risk breast cancer survivors' expectations for symptom discussions during oncology follow-up.” JCO Oncology Practice 22 (10_suppl): 470. https://doi.org/10.1200/op.2026.22.10_suppl.470.

Harvard

Schumacher, J. R. et al. (2026) ‘Low-risk breast cancer survivors' expectations for symptom discussions during oncology follow-up.’, JCO Oncology Practice, 22(10_suppl), p. 470. doi:10.1200/op.2026.22.10_suppl.470.

IEEE

J. R. Schumacher et al., “Low-risk breast cancer survivors' expectations for symptom discussions during oncology follow-up.,” JCO Oncology Practice, vol. 22, no. 10_suppl, p. 470, 2026, doi: 10.1200/op.2026.22.10_suppl.470.

BibTeX

@article{schumacher2026risk,
  title     = {{Low-risk breast cancer survivors' expectations for symptom discussions during oncology follow-up.}},
  author    = {Schumacher, Jessica R. and Hanlon, Bret M. and Breuer, Catherine Rae and Stalter, Lily N. and McKinney, Grace and Commers, Winifred L. S. and Kwekkeboom, Kristine L. and Flynn, Kathryn E. and Haine, James Edward and Neuman, Heather B},
  journal   = {JCO Oncology Practice},
  year      = {2026},
  volume    = {22},
  number    = {10_suppl},
  pages     = {470},
  doi       = {10.1200/op.2026.22.10_suppl.470},
  url       = {https://doi.org/10.1200/op.2026.22.10_suppl.470}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Oncology › Cancer survivorship and care

  • breast cancer survivors
  • low-risk breast cancer
  • patient expectations
  • oncology follow-up
  • patient-reported outcomes
  • survivorship care
  • endocrine therapy
  • lymphedema

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Schumacher, J. R., Hanlon, B. M., Breuer, C. R., Stalter, L. N., McKinney, G., Commers, W. L. S., Kwekkeboom, K. L., Flynn, K. E., Haine, J. E., & Neuman, H. B. (2026). Low-risk breast cancer survivors' expectations for symptom discussions during oncology follow-up. JCO Oncology Practice, 22(10_suppl), 470. https://doi.org/10.1200/op.2026.22.10_suppl.470

How many times has this paper been cited?

0 times, according to OpenAlex on 22 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at JCO Oncology Practice: sign in and open the PDF from this page.

Who wrote this paper?

Jessica R. Schumacher, Bret M. Hanlon, Catherine Rae Breuer, Lily N. Stalter, Grace McKinney, Winifred L. S. Commers, Kristine L. Kwekkeboom, Kathryn E. Flynn, James Edward Haine, Heather B Neuman.

What is the DOI of this paper?

10.1200/op.2026.22.10_suppl.470, permanently at https://doi.org/10.1200/op.2026.22.10_suppl.470. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 22 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.